Methyl N-methylglycinate hydrochloride structure
|
Common Name | Methyl N-methylglycinate hydrochloride | ||
---|---|---|---|---|
CAS Number | 13515-93-0 | Molecular Weight | 139.581 | |
Density | 0.964g/cm3 | Boiling Point | 118.9ºC at 760 mmHg | |
Molecular Formula | C4H10ClNO2 | Melting Point | 117-119 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 25.7ºC | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Use of Methyl N-methylglycinate hydrochlorideMethyl N-methylglycinate hydrochloride is a Glycine (HY-Y0966) derivative[1]. |
Name | Sarcosine methyl ester hydrochloride |
---|---|
Synonym | More Synonyms |
Description | Methyl N-methylglycinate hydrochloride is a Glycine (HY-Y0966) derivative[1]. |
---|---|
Related Catalog | |
In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
References |
Density | 0.964g/cm3 |
---|---|
Boiling Point | 118.9ºC at 760 mmHg |
Melting Point | 117-119 °C(lit.) |
Molecular Formula | C4H10ClNO2 |
Molecular Weight | 139.581 |
Flash Point | 25.7ºC |
Exact Mass | 139.040009 |
PSA | 38.33000 |
LogP | 0.57170 |
Vapour Pressure | 16.3mmHg at 25°C |
Index of Refraction | 1.4 |
Storage condition | Store at RT. |
SECTION 1: Identification of the substance/mixture and of the company/undertaking Product identifiers Product name: Sarcosine methyl ester hydrochloride REACH No.: A registration number is not available for this substance as the substance or its uses are exempted from registration, the annual tonnage does not require a registration or the registration is envisaged for a later registration deadline.
CAS-No.: 13515-93-0 Relevant identified uses of the substance or mixture and uses advised against Identified uses: Laboratory chemicals, Manufacture of substances SECTION 2: Hazards identification Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Skin irritation (Category 2), H315 Serious eye damage (Category 1), H318 Specific target organ toxicity - single exposure (Category 3), H335 For the full text of the H-Statements mentioned in this Section, see Section 16. Classification according to EU Directives 67/548/EEC or 1999/45/EC Xn HarmfulR22, R37/38, R41 For the full text of the R-phrases mentioned in this Section, see Section 16. Label elements Labelling according Regulation (EC) No 1272/2008 Pictogram Signal wordDanger Hazard statement(s) H302Harmful if swallowed. H315Causes skin irritation. H318Causes serious eye damage. H335May cause respiratory irritation. Precautionary statement(s) P261Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P280Wear protective gloves/ eye protection/ face protection. P305 + P351 + P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Supplemental Hazardnone Statements Other hazards - none SECTION 3: Composition/information on ingredients Substances Formula: C4H9NO2 · HCl Molecular Weight: 139,58 g/mol CAS-No.: 13515-93-0 EC-No.: 236-853-2 Hazardous ingredients according to Regulation (EC) No 1272/2008 ComponentClassificationConcentration Methyl N-methylaminoacetate hydrochloride CAS-No.13515-93-0Acute Tox. 4; Skin Irrit. 2; Eye <= 100 % EC-No.236-853-2Dam. 1; STOT SE 3; H302, H315, H318, H335 Hazardous ingredients according to Directive 1999/45/EC ComponentClassificationConcentration Methyl N-methylaminoacetate hydrochloride CAS-No.13515-93-0Xn, R22 - R37/38 - R41<= 100 % EC-No.236-853-2 For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16 SECTION 4: First aid measures Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 Indication of any immediate medical attention and special treatment needed no data available SECTION 5: Firefighting measures Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards arising from the substance or mixture Carbon oxides, nitrogen oxides (NOx), Hydrogen chloride gas Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. Further information no data available SECTION 6: Accidental release measures Personal precautions, protective equipment and emergency procedures Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. For personal protection see section 8. Environmental precautions Do not let product enter drains. Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal. Reference to other sections For disposal see section 13. SECTION 7: Handling and storage Precautions for safe handling Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2. Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Hygroscopic. Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated SECTION 8: Exposure controls/personal protection Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment Eye/face protection Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. Full contact Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: 480 min Material tested:Dermatril® (KCL 740 / Z677272, Size M) Splash contact Material: Nitrile rubber Minimum layer thickness: 0,11 mm Break through time: 480 min Material tested:Dermatril® (KCL 740 / Z677272, Size M) data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, test method: EN374 If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It should not be construed as offering an approval for any specific use scenario. Body Protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Do not let product enter drains. SECTION 9: Physical and chemical properties Information on basic physical and chemical properties a) AppearanceForm: powder Colour: beige b) Odourno data available c) Odour Thresholdno data available d) pHno data available e) Melting point/freezingMelting point/range: 117 - 119 °C point f) Initial boiling point and no data available boiling range g) Flash pointno data available h) Evapouration rateno data available i) Flammability (solid, gas) no data available j) Upper/lowerno data available flammability or explosive limits k) Vapour pressureno data available l) Vapour densityno data available m) Relative densityno data available n) Water solubilityno data available o) Partition coefficient: n- log Pow: -0,529 octanol/water p) Auto-ignitionno data available temperature q) Decompositionno data available temperature r) Viscosityno data available s) Explosive propertiesno data available t) Oxidizing propertiesno data available Other safety information no data available SECTION 10: Stability and reactivity Reactivity no data available Chemical stability Stable under recommended storage conditions. Possibility of hazardous reactions no data available Conditions to avoid no data available Incompatible materials Strong oxidizing agents Hazardous decomposition products Other decomposition products - no data available In the event of fire: see section 5 SECTION 11: Toxicological information Information on toxicological effects Acute toxicity no data available Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitisation no data available Germ cell mutagenicity no data available Carcinogenicity IARC:No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. Reproductive toxicity no data available Specific target organ toxicity - single exposure Inhalation - May cause respiratory irritation. Specific target organ toxicity - repeated exposure no data available Aspiration hazard no data available Additional Information RTECS: Not available SECTION 12: Ecological information Toxicity no data available Persistence and degradability no data available Bioaccumulative potential no data available Mobility in soil no data available Results of PBT and vPvB assessment PBT/vPvB assessment not available as chemical safety assessment not required/not conducted Other adverse effects no data available SECTION 13: Disposal considerations Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging Dispose of as unused product. SECTION 14: Transport information UN number ADR/RID: -IMDG: -IATA: - UN proper shipping name ADR/RID: Not dangerous goods IMDG: Not dangerous goods IATA:Not dangerous goods Transport hazard class(es) ADR/RID: -IMDG: -IATA: - Packaging group ADR/RID: -IMDG: -IATA: - Environmental hazards ADR/RID: noIMDG Marine pollutant: noIATA: no Special precautions for user no data available SECTION 15: Regulatory information This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. Safety, health and environmental regulations/legislation specific for the substance or mixture no data available Chemical Safety Assessment For this product a chemical safety assessment was not carried out SECTION 16: Other information Full text of H-Statements referred to under sections 2 and 3. Acute Tox.Acute toxicity Eye Dam.Serious eye damage H302Harmful if swallowed. H315Causes skin irritation. H318Causes serious eye damage. H335May cause respiratory irritation. Skin Irrit.Skin irritation STOT SESpecific target organ toxicity - single exposure Full text of R-phrases referred to under sections 2 and 3 XnHarmful R22Harmful if swallowed. R37/38Irritating to respiratory system and skin. R41Risk of serious damage to eyes. Further information Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use only. The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Corporation and its Affiliates shall not be held liable for any damage resulting from handling or from contact with the above product. See and/or the reverse side of invoice or packing slip for additional terms and conditions of sale. |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H315-H318-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R22;R37/38;R41 |
Safety Phrases | S26-S39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2922499990 |
~97% Methyl N-methyl... CAS#:13515-93-0 |
Literature: Ryakhovsky, Vladimir V.; Ivanov, Andrey S. Tetrahedron, 2012 , vol. 68, # 35 p. 7070 - 7076 |
~92% Methyl N-methyl... CAS#:13515-93-0 |
Literature: Ohishi; Mukai; Nagahara; Yajima; Kajikawa Chemical and Pharmaceutical Bulletin, 1989 , vol. 37, # 9 p. 2398 - 2405 |
~% Methyl N-methyl... CAS#:13515-93-0 |
Literature: US5066784 A1, ; |
~% Methyl N-methyl... CAS#:13515-93-0 |
Literature: Bulletin of the Chemical Society of Japan, , vol. 77, # 6 p. 1187 - 1193 |
~% Methyl N-methyl... CAS#:13515-93-0 |
Literature: Journal of Physical Organic Chemistry, , vol. 17, # 5 p. 448 - 457 |
Precursor 5 | |
---|---|
DownStream 10 | |
HS Code | 2923900090 |
---|---|
Summary | 2923900090 other quaternary ammonium salts and hydroxides。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
Role of transglutaminase in insulin release. Study with glycine and sarcosine methylesters.
Endocrinology 117(1) , 237-42, (1985) The Ca2+-responsive enzyme transglutaminase, which catalyzes the cross-bridging of proteins, is present in pancreatic islet cells, but its participation in the process of insulin release remains to be... |
|
Inhibition of the formation of myotubes in vitro by inhibitors of transglutaminase.
Biochim. Biophys. Acta 762(3) , 429-36, (1983) The effects of competitive inhibitors of transglutaminase on the formation of myotubes by the fusion of myoblasts in vitro has been investigated. Myotube formation was inhibited when myoblasts from 11... |
|
Poly(N-acryloylsarcosine methyl ester) protein-resistant surfaces.
J. Phys. Chem. B 109(44) , 20923-8, (2005) A new class of protein-resistant film based on N-substituted glycine derivatives is described. Pulsed plasma deposited poly(N-acryloylsarcosine methyl ester) coatings are shown to be resistant toward ... |
Methyl N-methylglycinate hydrochloride (1:1) |
Methyl 2-(methylamino)acetate hydrochloride |
H-Sar-OMe·HCl |
methyl 2-(methylamino)acetate,hydrochloride |
Glycine, N-methyl-, methyl ester, hydrochloride |
EINECS 236-853-2 |
Glycine, N-methyl-, methyl ester, hydrochloride (1:1) |
Sarcosine Methyl Ester Hydrochloride |
MFCD00038876 |
Sarcosine methyl ester,hydrochloride |
H-Sar-OMe.HCl |
Methyl N-methylglycinate hydrochloride |